Access To Medicine Foundation | Access to Medicine Foundation

ACCESS TO MEDICINE INDEX 2022

Featured insights

Discover the latest at the Foundation

The 2021 AMR Benchmark pinpointed opportunities for companies. Did they take them?

New 2024 Index Methodology places greater focus on measuring patient reach

Explore per sector

R&D-based pharma companies

We encourage them to make their products accessible.

Generic medicine manufacturers

We empower the industry to become more responsive.

Medical gas companies

We stimulate the industry to ensure availability for treatments and procedures.

Diagnostic companies

We forge partnerships to unlock the potential of diagnostics.

Vaccine manufacturers

We guide them to improve access to immunisation.

Resource centre

Explore our research reports and publications

How improving access to essential medicines can help reduce inequities

Are pharma companies addressing sexual and reproductive health access barriers for women and girls?

18 November 2022

Companies are engaging in adaptive R&D, tailoring products to the needs of people in LMICs

26 September 2023

How companies compare

Learn more about how pharmaceutical companies perform in the Access to Medicine Index

Explore our cross-sector programmes

Antimicrobial resistance programme

Diabetes care programme

Events and engagements

SHARING OUR INSIGHTS TO HELP DRIVE CHANGE

Bram Wagner presents Foundation’s work to pharmacy students exploring career opportunities

25 November 2023

Foundation to share insights on expanding access to insulin at ACCISS Study Meeting

04 December 2023

Foundation hosts webinar with WHO on the way forward for responsible manufacturing in addressing AMR

22 November 2023

Media coverage

Read more about our coverage in global media

Generic makers fall short when providing access to low- and middle-income countries, analysis finds

29 September 2023

Generic Drugmaking Firms Fall Short for Poorest Patients

26 September 2023